Showing results (991-1000 of 1,055) with videos related to
Sort By:
Pageof 106
Advanced Drug Delivery Reviews|September 1, 2009
Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactionsValerian E Kagan, Peter Wipf, Detcho Stoyanovsky, et al.Leukemia|August 17, 2011
Endogenous knockdown of survivin improves chemotherapeutic response in ALL modelsD J Morrison, L E Hogan, G Condos, et al.Frontiers in Genetics|October 7, 2022
Vici syndrome in Israel: Clinical and molecular insightsOdelia Chorin, Yoel Hirsch, Rachel Rock, et al.Radiation Research|April 21, 2022
Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian CancerDiala F Hamade, Alexis Espinal, Jian Yu, et al.Antioxidants & Redox Signaling|August 25, 2017
"Only a Life Lived for Others Is Worth Living": Redox Signaling by Oxygenated Phospholipids in Cell Fate DecisionsYulia Y Tyurina, Indira Shrivastava, Vladimir A Tyurin, et al.The Journal of Allergy and Clinical Immunology|January 31, 2012
Fungi and allergic lower respiratory tract diseasesAlan P Knutsen, Robert K Bush, Jeffrey G Demain, et al.Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 24, 2018
Genetic re-engineering of polyunsaturated phospholipid profile of Saccharomyces cerevisiae identifies a novel role for Cld1 in mitigating the effects of cardiolipin peroxidationWenjia Lou, Hsiu-Chi Ting, Christian A Reynolds, et al.Cancer Research|April 19, 2003
HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivoFrank Loganzo, Carolyn M Discafani, Tami Annable, et al.The Lancet. Infectious Diseases|December 13, 2025
Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort studySmadar Eventov Friedman, Noa Ofek Shlomai, Esther Oiknine-Djian, et al.Radiation Research|January 21, 2016
Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) MiceAshwin Shinde, Hebist Berhane, Byung Han Rhieu, et al.Pageof 106